- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01085188
Effectiveness of Assertive Continuing Care for Youth
March 10, 2010 updated by: Chestnut Health Systems
Following discharge from residential treatment 324 adolescents are randomly assigned to Assertive Continuing Care with and without motivational incentives in a 2 x 2 factorial design.
Clinical outcomes are assessed at 3, 6, 9, and 12 months post discharge.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
342
Phase
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Met DSM-IV diagnostic criteria for abuse or dependence on alcohol or another drug in the past year
- Been between the ages of 12 and 18 at the time of residential admission; and (c) resided in one of ten Illinois counties targeted for the intervention
Exclusion Criteria:
- left residential treatment prior to the seventh day
- did not return to a target county at discharge
- showed evidence of cognitive impairment that interfered with understanding of study instruments, procedures, or the informed consent process
- were deemed dangerous to themselves or others during treatment
- were a ward of child protective services and inaccessible for the intervention
- met DSM-IV criteria for pathological gambling
- were discharged to the state department of corrections
- were already participating in a treatment study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Assertive Continuing Care (ACC)
Behavioral intervention comprised of the community reinforcement approach plus case management delivered in home and other community settings to youth and their caregivers.
|
Weekly community based behavioral counseling and case management
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
|
EXPERIMENTAL: Contingency Management (CM)
Using a prize drawing system (no, low, medium and large value prizes) with adolescents could earn escalating prize drawing opportunities by completing verifiable pro-social activities and providing negative urine test and breath alcohol test results.
|
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Weekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results
|
EXPERIMENTAL: ACC + CM
This arm is the combination of arms 1 and 2.
|
Weekly community based behavioral counseling and case management
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Weekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results
|
ACTIVE_COMPARATOR: Usual Continuing Care (UCC)
UCC consists of a discharge recommendation to seek aftercare services at nearest treatment provider to where the patient lived.
This service primarily consisted of outpatient group counseling.
|
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2003
Primary Completion (ACTUAL)
January 1, 2008
Study Registration Dates
First Submitted
March 10, 2010
First Submitted That Met QC Criteria
March 10, 2010
First Posted (ESTIMATE)
March 11, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
March 11, 2010
Last Update Submitted That Met QC Criteria
March 10, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1018-1201
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingSubstance Use | Substance Use Disorders | Substance DependenceUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Istanbul UniversityCompletedSubstance Use | Substance Use Disorders | Substance AbuseTurkey
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Brown UniversityNational Institute on Drug Abuse (NIDA)Recruiting
Clinical Trials on ACC
-
Fraunhofer-Institute of Toxicology and Experimental...M et P Pharma AGCompletedRhinitis, Allergic, SeasonalGermany
-
University of WashingtonInstitute of Education SciencesRecruiting
-
PfizerJANSSEN Alzheimer Immunotherapy Research & Development, LLCTerminatedAlzheimer DiseaseUnited States
-
PfizerJANSSEN Alzheimer Immunotherapy Research & Development, LLCCompletedAlzheimer DiseaseSpain, France, Germany
-
VA Office of Research and DevelopmentUniversity of Florida; Brooks RehabilitationCompleted
-
PfizerJANSSEN Alzheimer Immunotherapy Research & Development, LLCTerminated
-
San Diego State UniversityCompletedStress Disorders, Post-TraumaticUnited States
-
San Diego State UniversityCompletedStress Disorders, Post-traumaticUnited States
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedChest Pain | Acute Coronary SyndromeUnited States
-
Hospital for Special Surgery, New YorkRecruiting